For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

PGP120

4493MW

Dr.Anushka Jaisinh Raorane
Membership No Author Name Email Mobile
4493MW Dr.Anushka Jaisinh Raorane anushkaraorane18@gmail.com 9921421052
Cornea, Ocular Surface and External Eye Diseases

Efficacy of Intraoperative Subconjunctival Bevacizumab as Adjunct to Conjunctival Autograft in Primary Pterygium: A Prospective Interventional Study

Purpose: To evaluate intraoperative subconjunctival bevacizumab as an adjunct to conjunctival limbal autograft (CLAT) in primary pterygium.

Methods: Prospective interventional study of 30 eyes with primary progressive pterygium: Group A (n=15) CLAT alone, Group B (n=15) CLAT + 0.05 ml subconjunctival bevacizumab. Follow-up at day 1, day 7, 1 and 3 months for recurrence, complications, keratometry and astigmatism. Analysis used t-test/Mann-Whitney and Fisher's exact test (p<0.05).

Results: Baseline characteristics were comparable. Astigmatism reduced significantly in both groups, without significant intergroup difference at 3 months. No recurrence occurred. Day 7 watering was significantly higher with bevacizumab; other complications did not differ.

Conclusion: Both techniques corrected astigmatism with no recurrence at 3 months. Bevacizumab gave no added benefit and increased early watering. This is an ongoing study; longer follow-up and larger sample are needed.

Membership No Author Name Email Mobile
4701 Dr.Raghavendra K Ijeri drraghu.ijeri@gmail.com 9448751669